KLK3 and prostate cancer: Recently, a Korean Prostate Cancer Database registry-based analysis demonstrated that the PSA levels, surgical GS ≥8, adverse pathological features [PSM, SVI, ECE], and adverse laboratory features (detectable PSA levels after 6 weeks) were significant predictors of BCR-free survival and overall survival (OS) following RP in Korea [6].